VECAMYL® (mecamylamine HCI) is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension.
Malignant hypertension is extremely high blood pressure that develops suddenly1. It can be a major concern for patients. VECAMYL is an oral anti-hypertensive medication and a ganglionic blocker, which can manage uncomplicated cases of malignant hypertension.
After your doctor has prescribed you VECAMYL, he or she will fill out
the VECAMYL Enrollment Form and fax it to the VECAMYL Total Care Program
From there, a dedicated VECAMYL Total Care Program representative
will contact you to arrange for your medication to be delivered
If you have questions about your VECAMYL prescription,
VECAMYL® (mecamylamine HCI tablets USP) 2.5 mg is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension.
VECAMYL® should not be used in people with mild, moderate high blood pressure that can suddenly fluctuate at different times of the day.
You should not use VECAMYL if you have a heart condition that reduces the flow of blood to the heart or had a recent heart attack.
Patients with a certain type of abnormal kidney function should use VECAMYL with caution, and those with increased levels of urea in their blood should not use VECAMYL.
In general, it is not advised to use VECAMYL if you are receiving antibiotics and sulfonamides.
Do not use VECAMYL if you have glaucoma. Do not use VECAMYL if your healthcare provider indicated you have organic pyloric stenosis.
You should not use VECAMYL if you previously had a serious allergic reaction to mecamylamine hydrochloride (the medicine in VECAMYL).
VECAMYL should be used with caution if you have a disease that reduces blood flow to the heart and brain, such as arteriosclerosis, or have had a recent stroke.
It is important before using VECAMYL that the function of your kidneys and heart are evaluated by your healthcare professional. With certain diseases that reduce blood flow to the kidneys, brain, or heart, some people may experience worsening of symptoms due to reduction of blood pressure with VECAMYL therapy.
Also, discuss with your healthcare provider if you have bladder or urinary problems as VECAMYL can make it difficult to completely empty one's bladder.
VECAMYL may cause dizziness, lightheadedness, or fainting, especially when rising from a sitting or lying position. This effect may be increased by alcoholic beverages, exercise, or during hot weather. Rising slowly may help prevent these effects.
Tell your healthcare provider if you experience tremors, jerky involuntary movements, mental aberrations, or convulsions after taking VECAMYL.
Immediately tell your healthcare provider if you experience loose bowel movements with stomach bloating and decreased rumbling.
Use VECAMYL as directed by your healthcare provider. The information of this website should not take place of talking to your doctor. If you have any questions about your condition or if you would like more information on VECAMYL, talk to your doctor or pharmacist. Only you and your doctor can decide if VECAMYL is right for you.
Do not stop using VECAMYL unless told so by your healthcare provider because suddenly stopping the drug may cause high blood pressure to return. A sudden rise in blood pressure may cause stroke or heart failure. However, the effects of VECAMYL may last from hours to days after one stops using the drug.
For more information about VECAMYL, including additional side effects, please see the Full Prescribing Information for VECAMYL.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/Safety/MedWatch/default.htm or call 1-800-FDA-1088. You may also report an adverse event by calling (800) 769-8874.
You are about to enter a site that is for US healthcare professionals only. By clicking “Confirm” below, you certify that you are a healthcare professional and that you wish to proceed to the Healthcare Professionals Only section of this site. Products or treatments described on this site are available in the US but may not be available in other countries.
I am a licensed healthcare professional and wish to proceed to the Healthcare Professionals section of this site.Confirm